Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

被引:36
|
作者
Al-Hamodi, Zaid [1 ]
Ismail, Ikram S. [2 ]
Saif-Ali, Riyadh [1 ,3 ]
Ahmed, Khaled A. [4 ]
Muniandy, Sekaran [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur 50603, Malaysia
[3] Sanaa Univ, Fac Med, Dept Biochem, Sanaa, Yemen
[4] Ibb Univ, Fac Dent, Ibb, Yemen
来源
关键词
CORONARY-HEART-DISEASE; INSULIN-RESISTANCE SYNDROME; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK-FACTORS; FIBRINOLYTIC SYSTEM; PREDICTIVE-VALUE; PLASMA; OBESITY; INFLAMMATION;
D O I
10.1186/1475-2840-10-23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolytic abnormalities. The aim of this study was to investigate the association of tPA and its inhibitor PAI-1 with type 2 diabetes (T2D) and MetS and interrelationship between PAI-1 and tPA activities and antigens in Malaysian T2D and normal subjects. Methods: The plasma activities and antigens of PAI-1 and tPA and the levels of the tPA/PAI-1 complex as well as serum insulin, parameter of the coronary risk panel and plasma glucose at fasting state were studied in 303 T2D subjects (227 with MetS and 76 without MetS), 131 normal non-diabetic non-metabolic subjects and 101 nondiabetic MetS subjects. Results: The PAI-1 activity was higher in subjects with T2D with MetS (P = 9.8 x 10(-19)) and non-diabetic subjects with MetS (P = 3.0 x 10(-15)), whereas the tPA activity was lower in T2D with MetS (P = 0.003) as compare to normal subjects. Plasma tPA antigen levels were higher in subjects with T2D with MetS (P = 8.9 x 10(-24)), T2D without MetS (P = 1.3 x 10(-13)) and non-diabetic MetS subjects (P = 0.002). The activity and antigen of PAI-1 in normal subjects were related to insulin resistance (P = 2.2 x 10(-4); 0.007). Additionally, the PAI-1 activity was associated with an increased waist circumference (P = 2.2 x 10(-4)) and decreased HDL-c (P = 0.005), whereas the tPA activity was associated with decreased FBG (P = 0.028). The highest correlation was between PAI-1 activity and its antigen (R-2 = 0.695, P = 1.1 x 10(-36)) in diabetic subjects. The tPA activity negatively correlated with its antigen (R-2 = -0.444, P = 7.7 x 10(-13)) in normal subjects and with the PAI-1 activity and antigen (R-2 = -0.319, P = 9.9 x 10(-12); R2 = -0.228, P = 3.4 x 10(-6)) in diabetic subjects. Conclusions: PAI-1 and tPA activities and antigens were associated with diabetes and MetS parameters in Malaysian subjects.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Plasminogen activator inhibitor-1
    Gils, A
    Declerck, PJ
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (17) : 2323 - 2334
  • [22] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA
    JORGENSEN, M
    PHILIPS, M
    THORSEN, S
    SELMER, J
    ZEUTHEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 872 - 878
  • [23] EFFECT OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON TISSUE-TYPE PLASMINOGEN ACTIVATOR-INDUCED FIBRINOLYSIS
    CARR, ME
    KRISHNAMURTI, C
    ALVING, BM
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 106 - 110
  • [24] GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    STASSEN, JM
    KIECKENS, L
    VANNUFFELEN, A
    DEMOL, M
    COLLEN, D
    MULLIGAN, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 764 - 764
  • [25] Regulation of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 by Hydrocortisone in Rat Primary Astrocytes
    Kwon, Kyoung Ja
    Cho, Kyu Suk
    Lee, Sung Hoon
    Kim, Jung Nam
    Joo, So Hyun
    Ryu, Jong Hoon
    Ignarro, Louis J.
    Han, Seol-Heui
    Shin, Chan Young
    JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (07) : 1059 - 1069
  • [26] Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schonlein purpura
    Besbas, N
    Erbay, A
    Saatci, U
    Ozdemir, S
    Bakkaloglu, A
    Ozen, S
    Topaloglu, R
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (01) : 95 - 98
  • [27] Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies
    Yasuda, S
    Tsutsumi, A
    Atsumi, T
    Bertolaccini, ML
    Ichikawa, K
    Khamashta, MA
    Hughes, GRV
    Koike, T
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (06) : 1192 - 1197
  • [28] Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
    Seok, Su-Jin
    Kim, Su-Ji
    Gil, Hyo-Wook
    Yang, Jong-Oh
    Lee, Eun-Young
    Hong, Sae-Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (04) : 474 - 481
  • [29] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction
    Ganti, AK
    Potti, A
    Yegnanarayan, R
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (02) : 80 - 84
  • [30] Plasminogen Activator Inhibitor-1 and Adiponectin Are Associated With Metabolic Syndrome Components
    Vecchiola, Andrea
    Garcia, Killen
    Gonzalez-Gomez, Luis M.
    Tapia-Castillo, Alejandra
    Artigas, Rocio
    Baudrand, Rene
    Kalergis, Alexis M.
    Carvajal, Cristian A.
    Fardella, Carlos E.
    AMERICAN JOURNAL OF HYPERTENSION, 2022, 35 (04) : 311 - 318